JNJ Total Return Analyzer

JNJ total return combines two components: the cumulative distributions you received from JNJ over the holding period, and the change in NAV (share price) across the same window. Many high-yield funds advertise distribution rates that look spectacular in isolation but mask meaningful NAV erosion. The analyzer above shows exactly how much of your JNJ return came from distributions versus price change — a 50% annualized distribution rate paired with a 30% NAV decline is a very different investment than a 50% distribution with flat NAV.

Johnson & Johnson (JNJ) is issued by J&J. Dividend King with 64 consecutive years of dividend increases — one of the most reliable dividend records on any U.S. exchange. Diversified healthcare giant focused on pharmaceuticals and medical devices since the Kenvue consumer-health spinoff in 2023. Annual dividend $5.36/share, forward yield ~2.3%, payout ratio ~50% on over $25B of projected free cash flow. Quarterly payer with the annual raise typically declared in April. That strategy directly shapes the gap between headline yield and real yield: option-premium and covered-call funds tend to show large gaps, while traditional dividend ETFs and index funds usually show small ones.

For the detail behind each payment, see the JNJ dividend history. To project how future JNJ distributions compound under DRIP, open the JNJ dividend calculator.